WCM Investment Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-11,474
Closed -$3.11M 256
2025
Q3
$3.11M Buy
+11,474
New +$3.13M 0.01% 179
2023
Q3
Sell
-3,504,371
Closed -$769M 221
2023
Q2
$769M Buy
3,504,371
+22,791
+0.7% +$5.08M 2.3% 13
2023
Q1
$762M Sell
3,481,580
-351,062
-9% -$76.2M 2.44% 14
2022
Q4
$798M Sell
3,832,642
-1,984,316
-34% -$436M 2.66% 13
2022
Q3
$1.27B Sell
5,816,958
-599,241
-9% -$136M 4.56% 6
2022
Q2
$1.37B Sell
6,416,199
-2,197,393
-26% -$468M 4.9% 6
2022
Q1
$2.09B Sell
8,613,592
-432,558
-5% -$105M 5.83% 3
2021
Q4
$2.36B Sell
9,046,150
-41,361
-0.5% -$10.7M 5.31% 6
2021
Q3
$2.4B Sell
9,087,511
-18,599
-0.2% -$5.09M 5.54% 5
2021
Q2
$2.24B Buy
9,106,110
+116,399
+1% +$24.5M 5.7% 6
2021
Q1
$1.74B Buy
8,989,711
+168,141
+2% +$33.7M 4.78% 8
2020
Q4
$1.88B Buy
8,821,570
+131,077
+2% +$26.1M 5.1% 8
2020
Q3
$1.49B Buy
8,690,493
+221,840
+3% +$41M 5.23% 8
2020
Q2
$1.63B Buy
8,468,653
+299,913
+4% +$49.1M 6.24% 5
2020
Q1
$1.2B Buy
8,168,740
+367,990
+5% +$58.6M 6.64% 5
2019
Q4
$1.21B Buy
7,800,750
+133,986
+2% +$19.3M 6.5% 7
2019
Q3
$1.04B Buy
7,666,764
+450,954
+6% +$59.1M 6.21% 7
2019
Q2
$881M Buy
7,215,810
+156,013
+2% +$17.3M 5.52% 8
2019
Q1
$734M Buy
7,059,797
+2,735,434
+63% +$282M 5.11% 8
2018
Q4
$492M Buy
+4,324,363
New +$463M 4.4% 9

Other funds holding RMD

WCM Investment Management's RMD Position: Q4 2025 in Review

WCM Investment Management sold out of ResMed (RMD) in Q4 2025, closing a stake of 11,474 shares — an estimated $3.11M sold.

WCM Investment Management first reported a position in RMD in Q4 2018 and held it in 20 quarters. The position peaked at $2.4B in Q3 2021. 945 funds tracked by Wall St. Rank hold RMD as of Q4 2025.

  • WCM Investment Management reported no remaining ResMed position as of Q4 2025 after selling out during the quarter.
  • WCM Investment Management sold 11,474 ResMed shares in Q4 2025, an estimated $3.11M.
  • WCM Investment Management first reported a position in ResMed in Q4 2018 and held it in 20 quarters.
  • WCM Investment Management's ResMed position peaked at $2.4B in Q3 2021.
  • 945 funds tracked by Wall St. Rank held ResMed as of Q4 2025.

Based on WCM Investment Management's 13F filing for Q4 2025, filed 9 Feb 2026.